Ghrelin	B:C0911014
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	B:C0229951
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	B:C0376450
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	B:C1283255
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	B:C0039215
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	B:C0026809
After	O
Bone	O
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

Ghrelin	O
Protects	O
the	O
Thymic	O
Epithelium	I:C0229951
From	O
Conditioning	O
-	I:C0376450
Regimen	I:C0376450
-	O
Induced	O
Damage	O
and	O
Promotes	O
the	O
Restoration	O
of	O
CD4	O
+	I:C0039215
T	I:C0039215
Cells	I:C0039215
in	O
Mice	O
After	O
Bone	B:C0005961
Marrow	I:C0005961
Transplantation	I:C0005961
.	O

The	O
delay	O
in	O
immune	B:C1960768
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	B:C0472699
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	B:C0472699
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	B:C1096197
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	B:C0029118
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	B:C0277556
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	B:C0040732
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

The	O
delay	O
in	O
immune	O
reconstitution	I:C1960768
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
(	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
)	O
,	O
especially	O
a	O
delay	O
in	O
central	O
immune	O
reconstitution	I:C1096197
,	O
leads	O
to	O
opportunistic	O
infections	I:C0029118
and	O
disease	O
relapse	I:C0277556
after	O
transplantation	O
and	O
affects	O
the	O
long	O
-	O
term	O
outcome	O
of	O
hematopoietic	B:C0472699
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

This	O
delay	O
is	O
mainly	O
attributable	O
to	O
thymic	B:C3897359
damage	I:C3897359
after	O
myeloablative	O
chemotherapy	I:C1513784
and	O
radiotherapy	O
METHODS	O
:	O

This	O
delay	O
is	O
mainly	O
attributable	O
to	O
thymic	O
damage	I:C3897359
after	O
myeloablative	B:C1513784
chemotherapy	I:C1513784
and	O
radiotherapy	O
METHODS	O
:	O

This	O
delay	O
is	O
mainly	O
attributable	O
to	O
thymic	O
damage	I:C3897359
after	O
myeloablative	O
chemotherapy	I:C1513784
and	O
radiotherapy	B:C1522449
METHODS	O
:	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	B:C0005961
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	O
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	B:C0005961
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	O
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	B:C0026809
and	O
administered	O
ghrelin	O
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	B:C0911014
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	O
(	O
ghrelin	B:C0911014
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	O
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	B:C0376450
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

We	O
established	O
a	O
model	O
of	O
allogeneic	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
(	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
)	O
in	O
mice	O
and	O
administered	O
ghrelin	O
(	O
ghrelin	O
)	O
7	O
days	O
before	O
the	O
conditioning	O
regimen	I:C0376450
or	O
the	O
day	O
after	O
bone	B:C0005961
marrow	I:C0005961
transplantation	I:C0005961
.	O

All	O
the	O
ghrelin	B:C0911014
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	B:C0026809
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	B:C0911014
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	B:C0376450
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	B:C0040113
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	B:C1283255
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	B:C0039215
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	B:C0005961
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	O
.	O

All	O
the	O
ghrelin	O
-	O
treated	O
mice	O
,	O
especially	O
those	O
administered	O
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
,	O
exhibited	O
more	O
intact	O
thymic	O
architecture	O
and	O
a	O
more	O
rapid	O
restoration	O
of	O
CD4	O
T	I:C0039215
lymphocytes	I:C0039215
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
than	O
those	O
of	O
the	O
corresponding	O
control	O
mice	B:C0026809
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	B:C1515131
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	B:C1515131
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	B:C0026809
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	B:C0332293
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	B:C0911014
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	B:C0376450
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	B:C0026809
at	O
28	O
days	O
after	O
bone	O
marrow	I:C0005961
transplantation	I:C0005961
.	O

Moreover	O
,	O
the	O
levels	O
of	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
(	O
T	O
cell	I:C1515131
receptor	I:C1515131
excision	I:C1515131
circles	I:C1515131
)	O
were	O
significantly	O
higher	O
in	O
the	O
mice	O
treated	O
with	I:C0332293
ghrelin	O
prior	O
to	O
the	O
conditioning	O
regimen	I:C0376450
than	O
in	O
the	O
control	O
mice	O
at	O
28	O
days	O
after	O
bone	B:C0005961
marrow	I:C0005961
transplantation	I:C0005961
.	O

Our	O
finding	B:C0243095
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	B:C0911014
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	B:C0040113
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	B:C0014609
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	B:C0376450
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	B:C0040113
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	B:C0205100
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	B:C0039215
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	B:C2004454
after	O
hematopoietic	O
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

Our	O
finding	O
s	O
suggest	O
that	O
ghrelin	O
may	O
be	O
a	O
novel	O
potential	O
therapeutic	O
approach	O
to	O
protecting	O
the	O
thymic	O
epithelium	O
from	O
conditioning	O
-	I:C0376450
regimen	I:C0376450
-	O
induced	O
damage	O
and	O
promoting	O
rapid	O
and	O
durable	O
thymic	O
and	O
peripheral	O
CD4	O
T	I:C0039215
cell	I:C0039215
recovery	O
after	O
hematopoietic	B:C0472699
stem	I:C0472699
cell	I:C0472699
transplantation	I:C0472699
.	O

